There were 1,755 press releases posted in the last 24 hours and 249,185 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image